Plain-English translation of NCT05838183 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is exploring how two lung conditions—interstitial lung disease (a scarring of the lungs) and obstructive sleep apnea (interrupted breathing during sleep)—affect patients, especially when they happen together. Researchers will use specialized breathing tests, sleep monitoring, and samples from your lungs to understand what causes these conditions and how they interact with each other.
Many patients have both of these conditions at the same time, but doctors don't fully understand why or how they influence each other. This study aims to find biological markers that could help doctors better diagnose and understand these diseases when they occur together.
You likely qualify if…
You likely don't qualify if…
You would undergo a sleep study where you wear a device that monitors your breathing overnight. You may also have a bronchoscopy procedure, where a thin tube is passed into your lungs to collect fluid and tissue samples for analysis. Researchers will study these samples along with your medical information to identify biological patterns that distinguish between the different conditions.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
Enrollment target
~70 participants
Started
September 2019
Primary completion
December 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dan Liu
Dan Liu
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.